# Effects of Interleukin-1 Inhibition on Vascular and Left Ventricular Function in Rheumatoid Arthritis Patients With Coronary Artery Disease

> **NCT01566201** · NA · COMPLETED · sponsor: **University of Athens** · enrollment: 80 (actual)

## Conditions studied

- Rheumatoid Arthritis
- Coronary Artery Disease
- Inflammation

## Interventions

- **DRUG:** anakinra
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01566201
- **Lead sponsor:** University of Athens
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2012-04
- **Final completion:** 2013-06
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2014-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01566201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01566201, "Effects of Interleukin-1 Inhibition on Vascular and Left Ventricular Function in Rheumatoid Arthritis Patients With Coronary Artery Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01566201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*